News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,060 Results
Type
Article (4257)
Company Profile (22)
Press Release (102781)
Section
Business (32162)
Career Advice (108)
Deals (5289)
Drug Delivery (5)
Drug Development (5509)
Employer Resources (11)
FDA (3221)
Job Trends (2082)
News (47307)
Policy (3899)
Tag
Academia (363)
Alliances (11158)
Alzheimer's disease (285)
Approvals (3225)
Artificial intelligence (52)
Bankruptcy (45)
Best Places to Work (1723)
Breast cancer (40)
Cancer (261)
Cardiovascular disease (15)
Career advice (99)
Clinical research (4201)
Collaboration (111)
COVID-19 (473)
C-suite (19)
Data (150)
Diagnostics (5631)
Earnings (10336)
Events (13447)
Executive appointments (57)
FDA (3324)
Funding (82)
GLP-1 (38)
Government (625)
Healthcare (2910)
Infectious disease (491)
Inflammatory bowel disease (12)
Interviews (12)
IPO (1797)
Job creations (401)
Job search strategy (94)
Layoffs (21)
Legal (534)
Lung cancer (26)
Lymphoma (18)
Manufacturing (35)
Medical device (2442)
Medtech (2442)
Mergers & acquisitions (3521)
Metabolic disorders (22)
Multiple sclerosis (12)
Neuroscience (322)
NextGen Class of 2024 (732)
Non-profit (545)
Northern California (234)
People (8923)
Phase I (1272)
Phase II (1784)
Phase III (1594)
Pipeline (51)
Postmarket research (214)
Preclinical (594)
Prostate cancer (22)
Radiopharmaceuticals (118)
Rare diseases (19)
Real estate (860)
Regulatory (2970)
Research institute (431)
Resumes & cover letters (15)
Southern California (177)
Startups (624)
United States (2065)
Vaccines (29)
Date
Last 7 days (67)
Last 30 days (288)
Last 365 days (5146)
2024 (5126)
2023 (6203)
2022 (10266)
2021 (9672)
2020 (9012)
2019 (6217)
2018 (4882)
2017 (5415)
2016 (5418)
2015 (6154)
2014 (4643)
2013 (4133)
2012 (4448)
2011 (4642)
2010 (4094)
Location
Africa (130)
Arizona (45)
Asia (5328)
Australia (1222)
California (470)
Canada (199)
China (24)
Colorado (31)
Connecticut (40)
Europe (15176)
Florida (59)
Georgia (29)
Illinois (67)
Indiana (14)
Japan (15)
Maine (19)
Maryland (65)
Massachusetts (274)
Michigan (55)
Minnesota (63)
Missouri (15)
New Hampshire (16)
New Jersey (92)
New Mexico (16)
New York (200)
North Carolina (158)
Northern California (234)
Ohio (18)
Pennsylvania (60)
South America (153)
Southern California (177)
Tennessee (14)
Texas (101)
Utah (49)
Virginia (23)
Washington State (43)
Wisconsin (19)
107,060 Results for "vela diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Vela Diagnostics announced a research collaboration with SRL Inc, a premier Japanese healthcare service company.
October 2, 2023
·
2 min read
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
MoonLake Immunotherapeutics today announced that the first patients have been screened at a U.S. trial site in its global Phase 3 clinical program, VELA, evaluating sonelokimab, an investigational Nanobody® designed to treat inflammatory disease, in patients with moderate-to-severe hidradenitis suppurativa (HS).
May 16, 2024
·
13 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus, for research use only.
July 26, 2022
·
2 min read
Drug Development
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund.
August 3, 2022
·
3 min read
Pharm Country
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes
Vela Diagnostics announced today the launch of its new PathoKey® MP UTI ID and AMR PCR Test for research use only (RUO*).
May 17, 2022
·
3 min read
Drug Development
Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on the Phase 1/2 VELA trial of BLU-222.
March 28, 2023
·
5 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Drug Development
Blueprint Medicines Announces Partial Clinical Hold for Phase 1/2 VELA Trial of BLU-222
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the company on February 8, 2023 that it has placed a partial clinical hold on the Phase 1/2 VELA trial of BLU-222 due to visual adverse events (AEs) observed in a limited number of patients.
February 10, 2023
·
6 min read
Pharm Country
Media Pooling Strategy to Increase Testing Throughput Added to Vela Diagnostics’ ViroKey SARS-CoV-2 RT-PCR Test v2.0
Vela Diagnostics has announced that its ViroKey® SARS-CoV-2 RT-PCR Test v2.0 now has the additional capability to be used for pooling, using a three-in-one media pooling strategy.
April 22, 2022
·
2 min read
1 of 10,706
Next
